Bectas Therapeutics, Inc. — Form D
Bectas Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-09. The offering totals $10.0M, of which $4.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-09
- Form: D
- Accession: 0002038826-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $4.2M
- Remaining: $5.8M
- Investors: 11
- Date of first sale: 2022-10-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-526249
Issuer
- Name: Bectas Therapeutics, Inc.
- CIK: 0002038826
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3262 WESTHEIMER ROAD, HOUSTON, TX, 77098
- Phone: 617-834-3476
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Lynda Chin | Director | Houston, TX |
| Jon A Brilliant | Executive Officer | Houston, TX |
| Ronan O'Hagan | Director | Houston, TX |
| Ronan O'Hagan | Executive Officer | Houston, TX |
Other filings by this issuer (1)
More